The Roles of Trim15 and UCHL3 in the Ubiquitin-Mediated Cell Cycle Regulation Katerina Jerabkova

Total Page:16

File Type:pdf, Size:1020Kb

The Roles of Trim15 and UCHL3 in the Ubiquitin-Mediated Cell Cycle Regulation Katerina Jerabkova The roles of Trim15 and UCHL3 in the ubiquitin-mediated cell cycle regulation Katerina Jerabkova To cite this version: Katerina Jerabkova. The roles of Trim15 and UCHL3 in the ubiquitin-mediated cell cycle regulation. Cellular Biology. Université de Strasbourg; Univerzita Karlova (Prague), 2019. English. NNT : 2019STRAJ034. tel-02884583 HAL Id: tel-02884583 https://tel.archives-ouvertes.fr/tel-02884583 Submitted on 30 Jun 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. UNIVERSITÉ DE STRASBOURG ÉCOLE DOCTORALE DES SCIENCES DE LA VIE ET DE LA SANTÉ IGBMC - CNRS UMR 7104 - Inserm U 1258 THÈSE présentée par : Kateřina JEŘÁBKOVÁ soutenue le : 09 Octobre 2019 pour obtenir le grade de : Docteur de l’université de Strasbourg Discipline/ Spécialité : Aspects moléculaires et cellulaires de la biologie Les rôles de Trim15 et UCHL3 dans la régulation, médiée par l’ubiquitine, du cycle cellulaire. The roles of Trim15 and UCHL3 in the ubiquitin-mediated cell cycle regulation. THÈSE dirigée par : Mme SUMARA Izabela PhD, Université de Strasbourg Mme CHAWENGSAKSOPHAK Kallayanee PhD, Charles University RAPPORTEURS : Mr LEON Sébastien PhD, Institut Jacques Monod Mr THORPE Peter PhD, Queen Mary University of London AUTRES MEMBRES DU JURY : Mr MENDOZA Manuel PhD, Université de Strasbourg Mr ŠOLC Petr PhD, Charles University Mr SEDLÁČEK Radislav PhD, Charles University -1- CO-TUTELLE PhD THESIS between Charles University (Czech Republic) Faculty of Science - Developmental and Cell Biology and University of Strasbourg (France) École doctorale des sciences de la vie et de la santé - ED 414 The roles of Trim15 and UCHL3 in the ubiquitin-mediated cell cycle regulation. Author: Kateřina Jeřábková Co-supervised by: Izabela Sumara, PhD Kallayanee Chawengsaksophak, PhD Assoc. Prof. Radislav Sedláček, PhD Committee members: Assoc. Prof. Petr Šolc, PhD Peter Thorpe, PhD Manuel Mendoza, PhD Sebastien Leon, PhD Strasbourg 2019 -2- DECLARATION I declare that I wrote the thesis myself and that I cited all the information sources and literature. This work or a substantial part of it was not presented to obtain another academic degree or equivalent. Prague .......................... ........................................... Kateřina Jeřábková FINANCIAL SUPPORT Charles University in Prague (doctoral fellowship), Fellowship from the French Government awarded by the Ministry for foreign affairs to study PhD in a co-tutelle program, Ligue Nationale Contre le Cancer (fellowship for the 4th year), LabEx. -3- Acknowledgements Words cannot explain how grateful I am for all the help I have received from everybody around me during my PhD, it has been a long journey and it seems almost unbelievable that I am writing this text, because it means that I have finished writing my thesis. During my PhD I have entered two labs in two different countries and I found many great people and good friends at both places. First of all, I would like to thank my three supervisors: Iza, Radek and Kallayanee who agreed to take me as a co-tutelle student which was a very challenging arrangement, but also a great experience. I would also like to thank Peter Thorpe, Sebastien Leon, Petr Šolc and Manuel Mendoza for agreeing to evaluate my thesis and to be part of my thesis committee. Special thanks belong to Iza for supervising my work on the UCHL3 project which was a big part of my PhD. I am very thankful that I got the opportunity to work in her lab and to contribute to this very exciting project in a nice lab atmosphere. I would especially like to thank Iza for the trust she gave me in choosing the scientific questions and the experimental setup. This complete support of my work was incredibly valuable and taught me a lot how to eventually become an independent scientist. I hope I will put this to good use in my future career. I would also like to thank Radek for taking me as a PhD student to join his lab and for supporting my idea to start a co tutelle study program. It was definitely not an easy way to go, but I am very grateful for this experience. My big thanks also belong to Kallayanee who was my supervisor at the Charles University and who was always giving me useful advice and supporting me throughout my whole study. I am also very grateful to Trevor for his comments to my project and also for correcting my application to the PhD program. I would like to thank all the members of Iza’s lab (Charlotte, Sushil, Arantxa, Eva, Yongrong and Paulo as well as the former members Steff and Ksenia) for their everyday help and support and especially to Yongrong who participated on the project and helped me with some key experiments. I would also like to thank Charlotte who helped me with cloning and who always made sure nothing is missing in the lab, which made the work much easier. Big thanks belong to Arantxa for great discussions about our projects, for the endless splitting of my cells and for being there for me whenever I needed help. I would like to thank Romeo Ricci and his team for the fruitful discussions during our lab meetings, it taught me how to develop critical thinking which I value a lot. -4- I also thank Snezhka Oliferenko, Didier Devys and Manuel Mendoza who were part of my mid-thesis committee and gave me very valuable comments on my project. I would like to thank Bill Keyes for discussing my project and also to Daniel from Bill’s lab for teaching me how to use the Cell Profiler. I would like to thank all the platforms at IGBMC and at IMG for facilitating my work, especially the cell culture facility, mediaprep, microscopy facility, flow cytometry and the glass washing service. Special and very big thanks belong to Matej who supported me in all aspects of the PhD and who helped me not only experimentally, but who also endlessly discussed my project and pointed out many important aspects of it. I would also like to thank Dominika, Silvia, Jolana, Petr, Olga and Lenka from Radek’s lab for teaching me different methods in the beginning of my PhD, because everything was very new and complicated. Special thanks belong to Björn Schuster who taught me many techniques regarding genome editing. I also thank Veronika, Shohag and Katka, my PhD labmates in Prague. Special thanks belong to Christiana who was always telling me that I can do it [the PhD] and for teaching me how to kill mice (ironically, always before lunch). I would also like to thank Martin for helping me with the migration experiments and to David for the large scale migration and proliferation assays. Many thanks belong to Marina with whom I collaborated on one project and who gave me many valuable scientific advices. I would like to thank all of my friends in Prague and in Strasbourg for being there for me at all times. Especially to Xieyang who helped me to practice all my big presentations (Xieyang, I hope you will Skype me before the thesis defense). I also thank to all my climbing friends whom I have abandoned around the fourth year of my PhD, but they never lost hope that I would come back climbing including Sandrine, Alastair, Arantxa, Xieyang, Renee, Yasmine, Merce, Irene, Vincent, Rocio and many more. Special thanks belong also to people who shared daily lunches and coffees with me and discussed science fun facts with me (Arantxa, Paulo, Alexia, Jordi, Xenia, Matej, Charlotte, Saurabh, Greg, Robert, Bea, Marina, Dimitra and Paula). I would like to also thank my closest friends, to my partner and to my family for the great amount of help, support and patience. Mami, tati, Helčo, Lucie, Mateji, díky moc za všechno, bylo to náročné, ale povedlo se, bez vás by to nešlo! -5- Contents CO-TUTELLE PHD THESIS ............................................................................................................. 2 DECLARATION ............................................................................................................................. 3 FINANCIAL SUPPORT ................................................................................................................... 3 ACKNOWLEDGEMENTS ............................................................................................................... 4 ABSTRACT (ENGLISH) ................................................................................................................ 10 ABSTRAKT (CZECH) .................................................................................................................... 12 SUMMARY (FRENCH) ................................................................................................................ 14 PROJECTS OUTLOOK ................................................................................................................. 20 LIST OF ABBREVIATIONS ............................................................................................................ 22 1 INTRODUCTION ............................................................................................................. 26 1.1 Ubiquitination .................................................................................................................................
Recommended publications
  • Cytogenomic SNP Microarray - Fetal ARUP Test Code 2002366 Maternal Contamination Study Fetal Spec Fetal Cells
    Patient Report |FINAL Client: Example Client ABC123 Patient: Patient, Example 123 Test Drive Salt Lake City, UT 84108 DOB 2/13/1987 UNITED STATES Gender: Female Patient Identifiers: 01234567890ABCD, 012345 Physician: Doctor, Example Visit Number (FIN): 01234567890ABCD Collection Date: 00/00/0000 00:00 Cytogenomic SNP Microarray - Fetal ARUP test code 2002366 Maternal Contamination Study Fetal Spec Fetal Cells Single fetal genotype present; no maternal cells present. Fetal and maternal samples were tested using STR markers to rule out maternal cell contamination. This result has been reviewed and approved by Maternal Specimen Yes Cytogenomic SNP Microarray - Fetal Abnormal * (Ref Interval: Normal) Test Performed: Cytogenomic SNP Microarray- Fetal (ARRAY FE) Specimen Type: Direct (uncultured) villi Indication for Testing: Patient with 46,XX,t(4;13)(p16.3;q12) (Quest: EN935475D) ----------------------------------------------------------------- ----- RESULT SUMMARY Abnormal Microarray Result (Male) Unbalanced Translocation Involving Chromosomes 4 and 13 Classification: Pathogenic 4p Terminal Deletion (Wolf-Hirschhorn syndrome) Copy number change: 4p16.3p16.2 loss Size: 5.1 Mb 13q Proximal Region Deletion Copy number change: 13q11q12.12 loss Size: 6.1 Mb ----------------------------------------------------------------- ----- RESULT DESCRIPTION This analysis showed a terminal deletion (1 copy present) involving chromosome 4 within 4p16.3p16.2 and a proximal interstitial deletion (1 copy present) involving chromosome 13 within 13q11q12.12. This
    [Show full text]
  • Expression Level and Prognostic Potential of MAP3K8 in Human Cancers Based on Data Mining
    Expression Level and Prognostic Potential of MAP3K8 in Human Cancers Based on Data Mining Jiatao Hao Xi'an Jiaotong University Medical College First Aliated Hospital Yumeng Cao China Medical University Hui Yu Xi'an Jiaotong University Medical College First Aliated Hospital Lu Zong Xi'an Jiaotong University Medical College First Aliated Hospital Ruifang An Xi'an Jiaotong University Medical College First Aliated Hospital Yan Xue ( [email protected] ) Xi'an Jiaotong University Medical College First Aliated Hospital https://orcid.org/0000-0002-6061- 1706 Primary research Keywords: MAPK kinase kinase 8 (MAP3K8), expression, methylation, prognosis, protein-protein interaction (PPI), functional enrichment analysis Posted Date: March 9th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-276370/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/22 Abstract Background: MAPK kinase kinase 8 (MAP3K8) is a member of the MAP3K family with a major role in the regulation of the MAPK pathway and immune response. Differential expression of MAP3K8 is closely correlated with tumorigenesis. In this study, we used bioinformatics tools to explore expression level, prognostic values, and interactive networks of MAP3K8 in human cancers. Methods: Expression prole of MAP3K8 was analyzed using the Oncomine Platform, the Gene Expression Proling Interactive Analysis (GEPIA), and UALCAN. Survival analysis was evaluated via UALCAN, GEPIA, and DriverDBv3 databases. Then, MAP3K8 related functional networks were explored within GeneMANIA and Cytoscape. Moreover, Metascape was used to analyze Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. Results: We found that MAP3K8 was down-expressed in most cancer samples compared with paired normal tissues.
    [Show full text]
  • UNIVERSITY of CALIFORNIA, SAN DIEGO Functional Analysis of Sall4
    UNIVERSITY OF CALIFORNIA, SAN DIEGO Functional analysis of Sall4 in modulating embryonic stem cell fate A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Molecular Pathology by Pei Jen A. Lee Committee in charge: Professor Steven Briggs, Chair Professor Geoff Rosenfeld, Co-Chair Professor Alexander Hoffmann Professor Randall Johnson Professor Mark Mercola 2009 Copyright Pei Jen A. Lee, 2009 All rights reserved. The dissertation of Pei Jen A. Lee is approved, and it is acceptable in quality and form for publication on microfilm and electronically: ______________________________________________________________ ______________________________________________________________ ______________________________________________________________ ______________________________________________________________ Co-Chair ______________________________________________________________ Chair University of California, San Diego 2009 iii Dedicated to my parents, my brother ,and my husband for their love and support iv Table of Contents Signature Page……………………………………………………………………….…iii Dedication…...…………………………………………………………………………..iv Table of Contents……………………………………………………………………….v List of Figures…………………………………………………………………………...vi List of Tables………………………………………………….………………………...ix Curriculum vitae…………………………………………………………………………x Acknowledgement………………………………………………….……….……..…...xi Abstract………………………………………………………………..…………….....xiii Chapter 1 Introduction ..…………………………………………………………………………….1 Chapter 2 Materials and Methods……………………………………………………………..…12
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • The Role of Model Organisms in the History of Mitosis Research
    Downloaded from http://cshperspectives.cshlp.org/ on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press The Role of Model Organisms in the History of Mitosis Research Mitsuhiro Yanagida Okinawa Institute of Science and Technology Graduate University, Okinawa 904-0495, Japan Correspondence: [email protected] Mitosis is a cell-cycle stage during which condensed chromosomes migrate to the middle of the cell and segregate into two daughter nuclei before cytokinesis (cell division) with the aid of a dynamic mitotic spindle. The history of mitosis research is quite long, commencing well before the discovery of DNA as the repository of genetic information. However, great and rapid progress has been made since the introduction of recombinant DNA technology and discovery of universal cell-cycle control. A large number of conserved eukaryotic genes required for the progression from early to late mitotic stages have been discovered, confirm- ing that DNA replication and mitosis are the two main events in the cell-division cycle. In this article, a historical overview of mitosis is given, emphasizing the importance of diverse model organisms that have been used to solve fundamental questions about mitosis. Onko Chisin—An attempt to discover new truths by checkpoint [SAC]), then metaphase (in which studying the past through scrutiny of the old. the chromosomes are aligned in the middle of cell), anaphase A (in which identical sister chro- matids comprising individual chromosomes LARGE SALAMANDER CHROMOSOMES separate and move toward opposite poles of ENABLED THE FIRST DESCRIPTION the cell), anaphase B (in which the spindle elon- OF MITOSIS gates as the chromosomes approach the poles), itosis means “thread” in Greek.
    [Show full text]
  • Genome-Wide Analysis of Differential Transcriptional and Epigenetic
    bioRxiv preprint doi: https://doi.org/10.1101/083246; this version posted October 26, 2016. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 Genome-wide Analysis of Differential Transcriptional and 2 Epigenetic Variability Across Human Immune Cell Types 3 Simone Ecker,1,2,* Lu Chen,3,4 Vera Pancaldi,1 Frederik O. Bagger,4,5,6 José María Fernández,1 Enrique Carrillo de 4 Santa Pau,1 David Juan,1 Alice L. Mann,3 Stephen Watt,3 Francesco Paolo Casale,6 Nikos Sidiropoulos,7,8,9 Nicolas 5 Rapin,7,8,9 Angelika Merkel,10 BLUEPRINT Consortium, Henk Stunnenberg,11 Oliver Stegle,6 Mattia Frontini,4,5,12 Kate 6 Downes,4,5 Tomi Pastinen,13 Taco W. Kuijpers,14,15 Daniel Rico,1,17 Alfonso Valencia,1,17 Stephan Beck,2,17 Nicole 7 Soranzo3,4,17,* and Dirk S. Paul2,16,17,* 8 9 1Structural Biology and Biocomputing Programme, Spanish National Cancer Research Center (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain 10 2UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK 11 3Department of Human Genetics, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1HH, UK 12 4Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Long Road, Cambridge, CB2 0PT, UK 13 5National Health Service (NHS) Blood and Transplant, Cambridge Biomedical Campus, Long Road, Cambridge, CB2
    [Show full text]
  • KLF6 Depletion Promotes NF-Κb Signaling in Glioblastoma
    OPEN Oncogene (2017) 36, 3562–3575 www.nature.com/onc ORIGINAL ARTICLE KLF6 depletion promotes NF-κB signaling in glioblastoma AP Masilamani1,2, R Ferrarese1,2, E Kling1,2, NK Thudi3, H Kim4, DM Scholtens5, F Dai1,2, M Hadler1,2, T Unterkircher1,2, L Platania1,2, A Weyerbrock1,2, M Prinz6,7, GY Gillespie8, GR Harsh IV9, M Bredel3,10 and MS Carro1,2,10 Dysregulation of the NF-κB transcription factor occurs in many cancer types. Krüppel-like family of transcription factors (KLFs) regulate the expression of genes involved in cell proliferation, differentiation and survival. Here, we report a new mechanism of NF- κB activation in glioblastoma through depletion of the KLF6 tumor suppressor. We show that KLF6 transactivates multiple genes negatively controlling the NF-κB pathway and consequently reduces NF-κB nuclear localization and downregulates NF-κB targets. Reconstitution of KLF6 attenuates their malignant phenotype and induces neural-like differentiation and senescence, consistent with NF-κB pathway inhibition. KLF6 is heterozygously deleted in 74.5% of the analyzed glioblastomas and predicts unfavorable patient prognosis suggesting that haploinsufficiency is a clinically relevant means of evading KLF6-dependent regulation of NF-κB. Together, our study identifies a new mechanism by which KLF6 regulates NF-κB signaling, and how this mechanism is circumvented in glioblastoma through KLF6 loss. Oncogene (2017) 36, 3562–3575; doi:10.1038/onc.2016.507; published online 6 February 2017 INTRODUCTION coding region have been controversial.16,18–22 KLF6 has been The NF-κB transcription factor family is oncogenic through proposed to perform its tumor suppression function by promoting suppression of programmed cell death, and promotion of tumor G1 cell cycle arrest mainly through cyclin-dependent kinase 15 growth and invasion.1 In tumors, NF-κB can be activated by inhibitor 1A (CDKN1A) promoter transactivation.
    [Show full text]
  • Chromosomes and Karyotypes
    Chromosomes and Karyotypes 1838 – Cell Theory, M.J. Schleiden and others (Schwann) 1842 – chromosomes first seen by Nageli 1865 – Charles Darwin, Pangenesis theory, blending inheritance 1865 - Gregor Mendel discovers, by crossbreeding peas, that specific laws govern hereditary traits. Each traits determined by pair of factors. 1869 - Friedrich Miescher isolates DNA for the first time, names it nuclein. 1882 – Walther Flemming describes threadlike ’chromatin’ in the nucleus that turns red with staining, studied and named mitosis. The term ‘chromosome’ used by Heinrich Waldeyer in 1888. 1902 – Mendel’s work rediscovered and appreciated (DeVries, Corens, etc) 1903 – Walter Sutton, the chromosomal theory of inheritance, chromosomes are the carriers of genetic information 1944 - Avery, MacLeod and McCarty show DNA was the genetic material 1953 - James Watson and Francis Crick discover the molecular structure of DNA: a double helix with base pairs of A + T and C + G. 1955 - human chromosome number first established 1999 - The first complete sequence of a human chromosome (22) was published. 2004 - Complete sequencing of the human genome was finished by an international public consortium. Craig Venter etc. Matthias Jakob Schleiden - 1838 proposes that cells are the basic structural elements of all plants. Cell Theory 1. All living organisms are composed of one or more cells 2. The cell is the basic unit of structure and organization of organisms Plate 1 from J. M. Schleiden, Principles of 3. All cells come from preexisting cells Scientific Botany, 1849, showing various features of cell development Weismann – Germline significance of meiosis for reproduction and inheritance - 1890 FIRST LAW: 1. Each trait due to a pair of hereditary factors which 2.
    [Show full text]
  • Supl Table 1 for Pdf.Xlsx
    BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) Gut Table S1. Proteomic analysis of liver tissues from 4-months old control and LPTENKO mice. Soluble Fraction Gene names LOG2FC CTL1 LOG2FC CTL2 LOG2FC CTL3 LOG2FC KO1 LOG2FC KO2 LOG2FC KO3 t-test adj Pvalue Aass 0.081686519 -0.097912098 0.016225579 -1.135271836 -0.860535624 -1.263037541 0.0011157 1.206072068 Acsm5 -0.125220746 0.071090866 0.054129881 -0.780692107 -0.882155692 -1.158378647 0.00189031 1.021713016 Gstm2 -0.12707966 0.572554941 -0.445475281 1.952813994 1.856518122 1.561376671 0.00517664 1.865316016 Gstm1 -0.029147714 0.298593425 -0.26944571 0.983159098 0.872028945 0.786125509 0.00721356 1.949464926 Fasn 0.08403202 -0.214149498 0.130117478 1.052480559 0.779734519 1.229308218 0.00383637 0.829422353 Upb1 -0.112438784 -0.137014769 0.249453553 -1.297732445 -1.181999331 -1.495303666 0.00102373 0.184442034 Selenbp2 0.266508271 0.084791964 -0.351300235 -2.040647809 -2.608780781 -2.039865739 0.00107121 0.165425127 Thrsp -0.15001075 0.177999342 -0.027988592 1.54283307 1.603048661 0.927443822 0.00453549 0.612858263 Hyi 0.142635733 -0.183013091 0.040377359 1.325929636 1.119934412 1.181313897 0.00044587 0.053553518 Eci1 -0.119041811 -0.014846366 0.133888177 -0.599970385 -0.555547972 -1.191875541 0.02292305 2.477981171 Aldh1a7 -0.095682449 -0.017781922 0.113464372 0.653424862 0.931724091 1.110750381 0.00356922 0.350756574 Pebp1 -0.06292058
    [Show full text]
  • Mir-17-92 Fine-Tunes MYC Expression and Function to Ensure
    ARTICLE Received 31 Mar 2015 | Accepted 22 Sep 2015 | Published 10 Nov 2015 DOI: 10.1038/ncomms9725 OPEN miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth Marija Mihailovich1, Michael Bremang1, Valeria Spadotto1, Daniele Musiani1, Elena Vitale1, Gabriele Varano2,w, Federico Zambelli3, Francesco M. Mancuso1,w, David A. Cairns1,w, Giulio Pavesi3, Stefano Casola2 & Tiziana Bonaldi1 The synergism between c-MYC and miR-17-19b, a truncated version of the miR-17-92 cluster, is well-documented during tumor initiation. However, little is known about miR-17-19b function in established cancers. Here we investigate the role of miR-17-19b in c-MYC-driven lymphomas by integrating SILAC-based quantitative proteomics, transcriptomics and 30 untranslated region (UTR) analysis upon miR-17-19b overexpression. We identify over one hundred miR-17-19b targets, of which 40% are co-regulated by c-MYC. Downregulation of a new miR-17/20 target, checkpoint kinase 2 (Chek2), increases the recruitment of HuR to c- MYC transcripts, resulting in the inhibition of c-MYC translation and thus interfering with in vivo tumor growth. Hence, in established lymphomas, miR-17-19b fine-tunes c-MYC activity through a tight control of its function and expression, ultimately ensuring cancer cell homeostasis. Our data highlight the plasticity of miRNA function, reflecting changes in the mRNA landscape and 30 UTR shortening at different stages of tumorigenesis. 1 Department of Experimental Oncology, European Institute of Oncology, Via Adamello 16, Milan 20139, Italy. 2 Units of Genetics of B cells and lymphomas, IFOM, FIRC Institute of Molecular Oncology Foundation, Milan 20139, Italy.
    [Show full text]
  • Whole Exome Sequencing in Families at High Risk for Hodgkin Lymphoma: Identification of a Predisposing Mutation in the KDR Gene
    Hodgkin Lymphoma SUPPLEMENTARY APPENDIX Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene Melissa Rotunno, 1 Mary L. McMaster, 1 Joseph Boland, 2 Sara Bass, 2 Xijun Zhang, 2 Laurie Burdett, 2 Belynda Hicks, 2 Sarangan Ravichandran, 3 Brian T. Luke, 3 Meredith Yeager, 2 Laura Fontaine, 4 Paula L. Hyland, 1 Alisa M. Goldstein, 1 NCI DCEG Cancer Sequencing Working Group, NCI DCEG Cancer Genomics Research Laboratory, Stephen J. Chanock, 5 Neil E. Caporaso, 1 Margaret A. Tucker, 6 and Lynn R. Goldin 1 1Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 2Cancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; 3Ad - vanced Biomedical Computing Center, Leidos Biomedical Research Inc.; Frederick National Laboratory for Cancer Research, Frederick, MD; 4Westat, Inc., Rockville MD; 5Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; and 6Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, USA ©2016 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol.2015.135475 Received: August 19, 2015. Accepted: January 7, 2016. Pre-published: June 13, 2016. Correspondence: [email protected] Supplemental Author Information: NCI DCEG Cancer Sequencing Working Group: Mark H. Greene, Allan Hildesheim, Nan Hu, Maria Theresa Landi, Jennifer Loud, Phuong Mai, Lisa Mirabello, Lindsay Morton, Dilys Parry, Anand Pathak, Douglas R. Stewart, Philip R. Taylor, Geoffrey S. Tobias, Xiaohong R. Yang, Guoqin Yu NCI DCEG Cancer Genomics Research Laboratory: Salma Chowdhury, Michael Cullen, Casey Dagnall, Herbert Higson, Amy A.
    [Show full text]
  • Post-Transcriptional Exon Shuffling Events in Humans Can Be Evolutionarily Conserved and Abundant
    Downloaded from genome.cshlp.org on September 23, 2021 - Published by Cold Spring Harbor Laboratory Press Research Post-transcriptional exon shuffling events in humans can be evolutionarily conserved and abundant Haya H. Al-Balool,1,7 David Weber,1,4,7 Yilei Liu,1,5 Mark Wade,1 Kamlesh Guleria,1,6 Pitsien Lang Ping Nam,1 Jake Clayton,1 William Rowe,1 Jonathan Coxhead,2 Julie Irving,2 David J. Elliott,1 Andrew G. Hall,3 Mauro Santibanez-Koref,1 and Michael S. Jackson1,8 1Institute of Genetic Medicine, Newcastle University, Newcastle NE1 3BZ, United Kingdom; 2NewGene Limited, Bioscience Building, International Centre for Life, Newcastle upon Tyne NE1 4EP, United Kingdom; 3Northern Institute for Cancer Research, Paul O’Gorman Building, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom In silico analyses have established that transcripts from some genes can be processed into RNAs with rearranged exon order relative to genomic structure (post-transcriptional exon shuffling, or PTES). Although known to contribute to transcriptome diversity in some species, to date the structure, distribution, abundance, and functional significance of human PTES transcripts remains largely unknown. Here, using high-throughput transcriptome sequencing, we identify 205 putative human PTES products from 176 genes. We validate 72 out of 112 products analyzed using RT-PCR, and identify additional PTES products structurally related to 61% of validated targets. Sequencing of these additional products reveals GT-AG dinucleotides at >95% of the splice junctions, confirming that they are processed by the spliceosome. We show that most PTES transcripts are expressed in a wide variety of human tissues, that they can be polyadenylated, and that some are conserved in mouse.
    [Show full text]